Cannabinoid Mechanisms of Pain Suppression 549Koga D, Santa T, Fukushima T, Homma H, Imai K (1997) Liquid chromatographic-atmo-
spheric pressure chemical ionization mass spectrometric determination of anandamide
and its analogs in rat brain and peripheral tissues. J Chromatogr B Biomed Sci Appl
690:7–13
Kosersky DS, Dewey WL, Harris LS (1973) Antipyretic, analgesic and anti-inflammatory
effects of delta 9-tetrahydrocannabinol in the rat. Eur J Pharmacol 24:1–7
Kozak KR, Rowlinson SW, Marnett LJ (2000) Oxygenation of the endocannabinoid, 2-
arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275:
33744–33749
Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, Marnett LJ
(2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide,
into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides.
J Biol Chem 277:44877–44885
Kruger L, Light AR, Schweizer FE (2003) Axonal terminals of sensory neurons and their
morphological diversity. J Neurocytol 32:205–216
LaMotte RH, Shain CN, Simone DA, Tsai EF (1991) Neurogenic hyperalgesia: psychophysical
studies of underlying mechanisms. J Neurophysiol 66:190–211
LaMotte RH, Lundberg LE, Torebjörk HE (1992) Pain, hyperalgesia and activity in nocicep-
tive C units in humans after intradermal injection of capsaicin. J Physiol 448:749–764
Landsman RS, Burkey TH, Consroe P, Roeske WR, Yamamura HI (1997) SR141716A is an
inverse agonist at the human cannabinoid CB1 receptor. Eur J Pharmacol 334:R1–R2
Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A,
Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to
cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.
Science 283:401–404
Leslie TA, Emson PC, Dowd PM, Woolf CJ (1995) Nerve growth factor contributes to the up-
regulation of growth- associated protein 43 and preprotachykinin A messenger RNAs in
primary sensory neurons following peripheral inflammation. Neuroscience 67:753–761
Li J, Daughters RS, Bullis C, Bengiamin R, Stucky MW, Brennan J, Simone DA (1999)
The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of
hyperalgesia produced by capsaicin in rats. Pain 81:25–33
LiL,ZhouXF(2001)PericellularGriffoniasimplicifoliaIisolectinB4-bindingringstructures
in the dorsal root ganglia following peripheral nerve injury in rats. J Comp Neurol
439:259–274
Lichtman AH, Martin BR (1991a) Cannabinoid-induced antinociception is mediated by
aspinalα2-noradrenergic mechanism. Brain Res 559:309–314
Lichtman AH, Martin BR (1991b) Spinal and supraspinal components of cannabinoid-
induced antinociception. J Pharmacol Exp Ther 258:517–523
Lichtman AH, Shelton CC, Advani T, Cravatt BF (2004) Mice lacking fatty acid amide hydro-
lase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain 109:319–327
Lim G, Sung B, Ji RR, Mao J (2003) Upregulation of spinal cannabinoid-1-receptors following
nerve injury enhances the effects of Win 55,212-2 on neuropathic pain behaviors in rats.
Pain 105:275–283
Luo C, Kumamoto E, Furue H, Chen J, Yoshimura M (2002) Anandamide inhibits excitatory
transmission to rat substantia gelatinosa neurones in a manner different from that of
capsaicin. Neurosci Lett 321:17–20
Mailleux P, Vanderhaeghen JJ (1992) Distribution of neuronal cannabinoid receptor in the
adult rat brain: a comparative receptor binding radioautography and in situ hybridiza-
tion histochemistry. Neuroscience 48:655–668
Malan TP, Ibrahim MM, Makriyannis A, Porreca F (2004) CB2 cannabinoid receptors may
produce peripheral analgesia by stimulating local release of endogenous opioids. 2004
Symposium on the Cannabinoids. International Cannabinoid Research Society, p 52
Malan TP Jr, Ibrahim MM, Deng H, Liu Q, Mata HP, Vanderah T, Porreca F, Makriyannis A
(2001)CB2cannabinoidreceptor-mediatedperipheralantinociception.Pain93:239–245